st kitts eye study grand rounds, artes 2009)
TRANSCRIPT
-
8/14/2019 St Kitts Eye Study Grand Rounds, Artes 2009)
1/53
The St Kitts Eye StudyGrand Rounds, January 2009
-
8/14/2019 St Kitts Eye Study Grand Rounds, Artes 2009)
2/53
Content
Background of Project
Screening
Protocol of the St Kitts Eye Study
What we have learned so far
Where do we go from here
-
8/14/2019 St Kitts Eye Study Grand Rounds, Artes 2009)
3/53
Federation of St Kitts and Nevis
-
8/14/2019 St Kitts Eye Study Grand Rounds, Artes 2009)
4/53
St Kitts
5 km
168 sq.km
35,000 inhabitants (2001 census)
-
8/14/2019 St Kitts Eye Study Grand Rounds, Artes 2009)
5/53
St Kitts and Halifax: Connections
-
8/14/2019 St Kitts Eye Study Grand Rounds, Artes 2009)
6/53
St Kitts and Halifax: Connections
1991: Eye Centre of Joseph N FranceHospital established, with help from Halifax
2001: first proposal for screening project
2003: funds from industryAlcon, Allergan, Merck, Pfizer
2005: it nearly happened2007: it nearly happened (again)
2008: it really happened.
-
8/14/2019 St Kitts Eye Study Grand Rounds, Artes 2009)
7/53
Glaucoma and black ancestry
St Lucia Study Ophthalmology (1989)
Baltimore Eye Survey Am J Epidem (1991)
The Barbados Eye Study Arch Ophth 1994)
Survey of Ophthalmology (2003)
-
8/14/2019 St Kitts Eye Study Grand Rounds, Artes 2009)
8/53
Glaucoma and black ancestry
prevalence 3 - 6 higher than in Caucasians
earlier onset & more rapid progression
5 larger prevalence of ocular hypertension (OHT)
risk of progression from OHT to glaucoma
rates of glaucoma-related blindness
Survey of Ophthalmology (2003)
-
8/14/2019 St Kitts Eye Study Grand Rounds, Artes 2009)
9/53
Glaucoma in the Caribbean
St Lucia Study Ophthalmology, 1989 Sep;96(9):1363-8
1679 individuals, aged 30+ years
VA, IOP, C/D ratio1/3 had supra-threshold screening fields on HFA
positives underwent definitive exam, including threshold fields
Prevalence of 8.8% in the 30+
y population.
-
8/14/2019 St Kitts Eye Study Grand Rounds, Artes 2009)
10/53
What is Screening?
Identify people whoprobablyhave a disease
from those thatprobably do not.
-
8/14/2019 St Kitts Eye Study Grand Rounds, Artes 2009)
11/53
The condition sought should be an important health problem.
There should be an accepted treatment.
The natural history of the disease should be well understood.
There should be a latent or early symptomatic stage.There should be a suitable and acceptable screening test.
Facilities for diagnosis and treatment should be available.
There should be an agreed policy on whom to treat as patients.
Early treatment should be of benefit.
The cost should be economically balanced.
Case finding should be a continuing process.
WHO criteria, after Wilson and Jungner (1968)
Glaucoma screening: worthwhile?
-
8/14/2019 St Kitts Eye Study Grand Rounds, Artes 2009)
12/53
The condition sought should be an important health problem.
There should be an accepted treatment.
The natural history of the disease should be well understood.
There should be a latent or early symptomatic stage.There should be a suitable and acceptable screening test.
Facilities for diagnosis and treatment should be available.
There should be an agreed policy on whom to treat as patients.
Early treatment should be of benefit.
The cost should be economically balanced.
Case finding should be a continuing process.
WHO criteria, after Wilson and Jungner (1968)
Glaucoma screening: worthwhile?
-
8/14/2019 St Kitts Eye Study Grand Rounds, Artes 2009)
13/53
The condition sought should be an important health problem.
There should be an accepted treatment.
The natural history of the disease should be well understood.
There should be a latent or early symptomatic stage.There should be a suitable and acceptable screening test.
Facilities for diagnosis and treatment should be available.
There should be an agreed policy on whom to treat as patients.
Early treatment should be of benefit.
The cost should be economically balanced.
Case finding should be a continuing process.
WHO criteria, after Wilson and Jungner (1968)
Glaucoma screening: worthwhile?
-
8/14/2019 St Kitts Eye Study Grand Rounds, Artes 2009)
14/53
The condition sought should be an important health problem.
There should be an accepted treatment.
The natural history of the disease should be well understood.
There should be a latent or early symptomatic stage.There should be a suitable and acceptable screening test.
Facilities for diagnosis and treatment should be available.
There should be an agreed policy on whom to treat as patients.
Early treatment should be of benefit.
The cost should be economically balanced.
Case finding should be a continuing process.
WHO criteria, after Wilson and Jungner (1968)
Glaucoma screening: worthwhile?
-
8/14/2019 St Kitts Eye Study Grand Rounds, Artes 2009)
15/53
The condition sought should be an important health problem.
There should be an accepted treatment.
The natural history of the disease should be well understood.
There should be a latent or early symptomatic stage.There should be a suitable and acceptable screening test.
Facilities for diagnosis and treatment should be available.
There should be an agreed policy on whom to treat as patients.
Early treatment should be of benefit.
The cost should be economically balanced.
Case finding should be a continuing process.
WHO criteria, after Wilson and Jungner (1968)
Glaucoma screening: worthwhile?
-
8/14/2019 St Kitts Eye Study Grand Rounds, Artes 2009)
16/53
The condition sought should be an important health problem.
There should be an accepted treatment.
The natural history of the disease should be well understood.
There should be a latent or early symptomatic stage.There should be a suitable and acceptable screening test.
Facilities for diagnosis and treatment should be available.
There should be an agreed policy on whom to treat as patients.
Early treatment should be of benefit.
The cost should be economically balanced.
Case finding should be a continuing process.
WHO criteria, after Wilson and Jungner (1968)
Glaucoma screening: worthwhile?
-
8/14/2019 St Kitts Eye Study Grand Rounds, Artes 2009)
17/53
The condition sought should be an important health problem.
There should be an accepted treatment.
The natural history of the disease should be well understood.
There should be a latent or early symptomatic stage.There should be a suitable and acceptable screening test.
Facilities for diagnosis and treatment should be available.
There should be an agreed policy on whom to treat as patients.
Early treatment should be of benefit.
The cost should be economically balanced.
Case finding should be a continuing process.
WHO criteria, after Wilson and Jungner (1968)
Glaucoma screening: worthwhile?
-
8/14/2019 St Kitts Eye Study Grand Rounds, Artes 2009)
18/53
The condition sought should be an important health problem.
There should be an accepted treatment.
The natural history of the disease should be well understood.
There should be a latent or early symptomatic stage.There should be a suitable and acceptable screening test.
Facilities for diagnosis and treatment should be available.
There should be an agreed policy on whom to treat as patients.
Early treatment should be of benefit.
The cost should be economically balanced.
Case finding should be a continuing process.
WHO criteria, after Wilson and Jungner (1968)
Glaucoma screening: worthwhile?
-
8/14/2019 St Kitts Eye Study Grand Rounds, Artes 2009)
19/53
The condition sought should be an important health problem.
There should be an accepted treatment.
The natural history of the disease should be well understood.
There should be a latent or early symptomatic stage.There should be a suitable and acceptable screening test.
Facilities for diagnosis and treatment should be available.
There should be an agreed policy on whom to treat as patients.
Early treatment should be of benefit.
The cost should be economically balanced.
Case finding should be a continuing process.
WHO criteria, after Wilson and Jungner (1968)
Glaucoma screening: worthwhile?
-
8/14/2019 St Kitts Eye Study Grand Rounds, Artes 2009)
20/53
The condition sought should be an important health problem.
There should be an accepted treatment.
The natural history of the disease should be well understood.
There should be a latent or early symptomatic stage.There should be a suitable and acceptable screening test.
Facilities for diagnosis and treatment should be available.
There should be an agreed policy on whom to treat as patients.
Early treatment should be of benefit.
The cost should be economically balanced.
Case finding should be a continuing process.
WHO criteria, after Wilson and Jungner (1968)
Glaucoma screening: worthwhile?
-
8/14/2019 St Kitts Eye Study Grand Rounds, Artes 2009)
21/53
Glaucoma screening: worthwhile?
S Hatt, R Wormald, J Burr
Cochrane Database of Systematic Reviews 2008Screening for prevention of optic nerve damage
due to chronic open angle glaucoma
Main results
As no trials were identified, no formal analysis
was performed.
-
8/14/2019 St Kitts Eye Study Grand Rounds, Artes 2009)
22/53
Glaucoma screening: worthwhile?
S Hatt, R Wormald, J Burr
Cochrane Database of Systematic Reviews 2008Screening for prevention of optic nerve damagedue to chronic open angle glaucoma
Main results
As no trials were identified, no formal analysiswas performed.
-
8/14/2019 St Kitts Eye Study Grand Rounds, Artes 2009)
23/53
The Bottom Line
Screeningcan be cost-effective in high-risk populations.
Most economic evaluations compare tocurrent model of routine case-finding byoptometrists, which does not exist inCaribbean.
Screening tests need very highspecificity to be workable.
-
8/14/2019 St Kitts Eye Study Grand Rounds, Artes 2009)
24/53
A good screening program
simple, cheap, and accessible
in peripheral health centres
rely on local expertise (nurses, assistants)
good sensitivity, and very high specificity
false-positive rate
-
8/14/2019 St Kitts Eye Study Grand Rounds, Artes 2009)
25/53
Likelihood ratios
sensitivity / (1 specificity)
-
8/14/2019 St Kitts Eye Study Grand Rounds, Artes 2009)
26/53
Likelihood ratios
sensitivity / (1 specificity)
Fagan Nomogram
-
8/14/2019 St Kitts Eye Study Grand Rounds, Artes 2009)
27/53
Likelihood ratios
sensitivity / (1 specificity)
Fagan Nomogram
-
8/14/2019 St Kitts Eye Study Grand Rounds, Artes 2009)
28/53
Likelihood ratios
sensitivity / (1 specificity)
Example:Moorfields Regression Analysis of HRT
Sensitivity = 65%, Specificity = 95%
Likelihood ratio = 0.65 / 0.05
= 13
Fagan Nomogram
-
8/14/2019 St Kitts Eye Study Grand Rounds, Artes 2009)
29/53
Brain Teaser
Sensitivity = 50%
Specificity = 95%
Prevalence = 0.3%
-
8/14/2019 St Kitts Eye Study Grand Rounds, Artes 2009)
30/53
Brain Teaser
Sensitivity = 50%
Specificity = 95%
Prevalence = 0.3%
What is the probability that a patient with
a positive test has the disease?
-
8/14/2019 St Kitts Eye Study Grand Rounds, Artes 2009)
31/53
Fagan Nomogram
-
8/14/2019 St Kitts Eye Study Grand Rounds, Artes 2009)
32/53
Fagan Nomogram
-
8/14/2019 St Kitts Eye Study Grand Rounds, Artes 2009)
33/53
Doctors with an average of 14 yrs experienceDoctors with an average of 14 yrs experience
Answers ranged from 1% to 99%Answers ranged from 1% to 99%
half of them estimating the probability as 50%half of them estimating the probability as 50%
Gigerenzer,Gigerenzer,
BMJ 2003;327:741-744BMJ 2003;327:741-744
5%
-
8/14/2019 St Kitts Eye Study Grand Rounds, Artes 2009)
34/53
help establish a robust
and effectivescreening
program for St Kitts and
wider Caribbean region
Aim - St Kitts Eye Study
-
8/14/2019 St Kitts Eye Study Grand Rounds, Artes 2009)
35/53
Questions - St Kitts Eye Study
Which tests provide high specificity and good
sensitivity, in a Caribbean population?
Which combination of tests provides the best
trade-off between performance and effort?
Can new technologies (eg HRT imaging)
improve on the current standard of care?
-
8/14/2019 St Kitts Eye Study Grand Rounds, Artes 2009)
36/53
Objectives St Kitts Eye Study
Examine a representative sample of 200
individuals >50 yrs with screening tests as
well as gold standard protocol.
Establish combination of screening tests
that provides specificity >98%.
Establish criteria for referral to Eye Centre.
-
8/14/2019 St Kitts Eye Study Grand Rounds, Artes 2009)
37/53
random sample of St Kitts residents (n=370)
drawn from Social Security list.
invited to participate by letter from Ministry
of Health
completeprotocol of tests, including
screening- and gold standard tests
Design St Kitts Eye Study
-
8/14/2019 St Kitts Eye Study Grand Rounds, Artes 2009)
38/53
Visual Fields
Frequency Doubling (Matrix) Perimetry
Moorfields Motion Displacement Perimetry
Suprathreshold (white-on-white) Perimetry(all screening tests on one eye only)
Humphrey 24-2 Sita-Standard (both eyes)
-
8/14/2019 St Kitts Eye Study Grand Rounds, Artes 2009)
39/53
-
8/14/2019 St Kitts Eye Study Grand Rounds, Artes 2009)
40/53
Tonometry
EasyEye NCT (Keeler)
Tonopen (Reichert)
Goldmann Applanation Tonometry (GAT)
-
8/14/2019 St Kitts Eye Study Grand Rounds, Artes 2009)
41/53
Imaging
Heidelberg Retina Tomograph (HRT2)
Nidek AFC 230 Stereo Fundus Camera
Dilated Fundus Examination (Volk 90D)
-
8/14/2019 St Kitts Eye Study Grand Rounds, Artes 2009)
42/53
Humphrey Matrix
1% supra-threshold test
Moorfields
Motion Displacement
Perimetry
HFA 76 point 3-zone
supra-threshold test
HFA 24-2 SITA Std
Threshold Visual Fields
Keeler EasyEye
Non-Contact Tonometry
Tonopen
Goldmann Applanation
Tonometry
Heidelberg Retina
Tomograph 2
Fundus Photography
Gonioscopy
Dilated exam of Anterior &
Posterior Segments
Clinical Decision &
Referral (if appropriate)
Consent, Interview,
Visual Acuity SKES: Protocol
-
8/14/2019 St Kitts Eye Study Grand Rounds, Artes 2009)
43/53
-
8/14/2019 St Kitts Eye Study Grand Rounds, Artes 2009)
44/53
-
8/14/2019 St Kitts Eye Study Grand Rounds, Artes 2009)
45/53
-
8/14/2019 St Kitts Eye Study Grand Rounds, Artes 2009)
46/53
Initial Findings
Invited:
373 individuals (169 women, 204 men)
age range 50 87 yrs
Participated:
172 individuals (46%) of those invited44 individuals (opportunistic)
208 (96%) completed entire program
-
8/14/2019 St Kitts Eye Study Grand Rounds, Artes 2009)
47/53
Initial Findings
Prevalence of glaucoma
18/172 = 10.5%
8 previously unknown (44%)
Prevalence of Ocular Hypertension
15/172 = 9%12 previously unknown (80%)
-
8/14/2019 St Kitts Eye Study Grand Rounds, Artes 2009)
48/53
Initial Findings*
Other conditions
Pterygium: almost universal
Significant cataract: ~25%
Diabetic Retinopathy: ??
AMD: very few
* No formal analysis conducted as yet
-
8/14/2019 St Kitts Eye Study Grand Rounds, Artes 2009)
49/53
Initial Findings*
Visual Fields
High rate of unreliable results with thresholdperimetry.
Moorfields Motion Displacement test easyto explain and well accepted.
Matrix Frequency Doubling: high rate of
abnormal test results
* No formal analysis conducted as yet
-
8/14/2019 St Kitts Eye Study Grand Rounds, Artes 2009)
50/53
Initial Findings*
Imaging
Optic disc size distribution different from
caucasians (larger number of large discs?)
Fundus photography: significant number of
nerve fibre layer defects as isolated finding.
* No formal analysis conducted as yet
-
8/14/2019 St Kitts Eye Study Grand Rounds, Artes 2009)
51/53
Initial Findings*
Tonometry
Non-contact tonometry surprisingly well
tolerated (but needs practice).
Impression: NCT appears more accurate &
precise compared to Tonopen.
* No formal analysis conducted as yet
-
8/14/2019 St Kitts Eye Study Grand Rounds, Artes 2009)
52/53
Where do we go from here?
Formal analysis of test performance,
compared to gold standard of clinical
examination.
Report to Ministry of Health, St Kitts and
Nevis, with suggested paradigm and cost
estimates.
-
8/14/2019 St Kitts Eye Study Grand Rounds, Artes 2009)
53/53
Younes Agoumi, Carol Beattie, Beulah &Terrela Byron, Balwantray Chauhan,Anthony Crouse, Stacey Durling, Marcelo